nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—migraine—Prednisone—ankylosing spondylitis	0.597	1	CpDpCtD
Eletriptan—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0449	0.15	CbGbCtD
Eletriptan—CYP2A6—Prednisolone—ankylosing spondylitis	0.0444	0.148	CbGbCtD
Eletriptan—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0262	0.0875	CbGbCtD
Eletriptan—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0231	0.0772	CbGbCtD
Eletriptan—CYP2C19—Prednisone—ankylosing spondylitis	0.0174	0.0579	CbGbCtD
Eletriptan—ABCB1—Betamethasone—ankylosing spondylitis	0.015	0.0502	CbGbCtD
Eletriptan—ABCB1—Prednisolone—ankylosing spondylitis	0.0148	0.0495	CbGbCtD
Eletriptan—ABCB1—Prednisone—ankylosing spondylitis	0.014	0.0468	CbGbCtD
Eletriptan—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0139	0.0462	CbGbCtD
Eletriptan—HTR1B—dura mater—ankylosing spondylitis	0.011	0.485	CbGeAlD
Eletriptan—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0108	0.0362	CbGbCtD
Eletriptan—HTR1D—dura mater—ankylosing spondylitis	0.0106	0.469	CbGeAlD
Eletriptan—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0105	0.035	CbGbCtD
Eletriptan—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00901	0.0301	CbGbCtD
Eletriptan—CYP3A4—Betamethasone—ankylosing spondylitis	0.00901	0.0301	CbGbCtD
Eletriptan—CYP3A4—Prednisolone—ankylosing spondylitis	0.00889	0.0297	CbGbCtD
Eletriptan—ABCB1—Dexamethasone—ankylosing spondylitis	0.00875	0.0292	CbGbCtD
Eletriptan—CYP3A4—Prednisone—ankylosing spondylitis	0.00839	0.028	CbGbCtD
Eletriptan—CYP2D6—Dexamethasone—ankylosing spondylitis	0.00824	0.0275	CbGbCtD
Eletriptan—ABCB1—Methotrexate—ankylosing spondylitis	0.00703	0.0235	CbGbCtD
Eletriptan—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00524	0.0175	CbGbCtD
Eletriptan—HTR2B—tendon—ankylosing spondylitis	0.000429	0.019	CbGeAlD
Eletriptan—HTR7—tendon—ankylosing spondylitis	0.000368	0.0162	CbGeAlD
Eletriptan—PTGS1—tendon—ankylosing spondylitis	0.000254	0.0112	CbGeAlD
Eletriptan—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000118	0.00146	CcSEcCtD
Eletriptan—Drowsiness—Methotrexate—ankylosing spondylitis	0.000118	0.00145	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000117	0.00145	CcSEcCtD
Eletriptan—Flushing—Prednisone—ankylosing spondylitis	0.000117	0.00145	CcSEcCtD
Eletriptan—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000117	0.00145	CcSEcCtD
Eletriptan—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000117	0.00145	CcSEcCtD
Eletriptan—Discomfort—Triamcinolone—ankylosing spondylitis	0.000117	0.00145	CcSEcCtD
Eletriptan—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000117	0.00145	CcSEcCtD
Eletriptan—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000116	0.00143	CcSEcCtD
Eletriptan—Angioedema—Betamethasone—ankylosing spondylitis	0.000115	0.00143	CcSEcCtD
Eletriptan—Angioedema—Dexamethasone—ankylosing spondylitis	0.000115	0.00143	CcSEcCtD
Eletriptan—Stomatitis—Methotrexate—ankylosing spondylitis	0.000115	0.00142	CcSEcCtD
Eletriptan—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000114	0.00141	CcSEcCtD
Eletriptan—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000114	0.00141	CcSEcCtD
Eletriptan—Immune system disorder—Prednisone—ankylosing spondylitis	0.000114	0.00141	CcSEcCtD
Eletriptan—Malaise—Betamethasone—ankylosing spondylitis	0.000114	0.00141	CcSEcCtD
Eletriptan—Malaise—Dexamethasone—ankylosing spondylitis	0.000114	0.00141	CcSEcCtD
Eletriptan—Oedema—Triamcinolone—ankylosing spondylitis	0.000114	0.00141	CcSEcCtD
Eletriptan—Vertigo—Dexamethasone—ankylosing spondylitis	0.000114	0.0014	CcSEcCtD
Eletriptan—Vertigo—Betamethasone—ankylosing spondylitis	0.000114	0.0014	CcSEcCtD
Eletriptan—Syncope—Dexamethasone—ankylosing spondylitis	0.000113	0.0014	CcSEcCtD
Eletriptan—Syncope—Betamethasone—ankylosing spondylitis	0.000113	0.0014	CcSEcCtD
Eletriptan—Arrhythmia—Prednisone—ankylosing spondylitis	0.000113	0.0014	CcSEcCtD
Eletriptan—Sweating—Methotrexate—ankylosing spondylitis	0.000113	0.00139	CcSEcCtD
Eletriptan—Shock—Triamcinolone—ankylosing spondylitis	0.000112	0.00138	CcSEcCtD
Eletriptan—Insomnia—Prednisolone—ankylosing spondylitis	0.000112	0.00138	CcSEcCtD
Eletriptan—Alopecia—Prednisone—ankylosing spondylitis	0.000112	0.00138	CcSEcCtD
Eletriptan—Shock—Methylprednisolone—ankylosing spondylitis	0.000112	0.00138	CcSEcCtD
Eletriptan—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000111	0.00137	CcSEcCtD
Eletriptan—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000111	0.00137	CcSEcCtD
Eletriptan—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000111	0.00137	CcSEcCtD
Eletriptan—Epistaxis—Methotrexate—ankylosing spondylitis	0.000111	0.00137	CcSEcCtD
Eletriptan—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000111	0.00137	CcSEcCtD
Eletriptan—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000111	0.00137	CcSEcCtD
Eletriptan—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000111	0.00137	CcSEcCtD
Eletriptan—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00011	0.00136	CcSEcCtD
Eletriptan—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00011	0.00136	CcSEcCtD
Eletriptan—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00011	0.00136	CcSEcCtD
Eletriptan—Convulsion—Dexamethasone—ankylosing spondylitis	0.000109	0.00135	CcSEcCtD
Eletriptan—Convulsion—Betamethasone—ankylosing spondylitis	0.000109	0.00135	CcSEcCtD
Eletriptan—Hypertension—Dexamethasone—ankylosing spondylitis	0.000109	0.00135	CcSEcCtD
Eletriptan—Hypertension—Betamethasone—ankylosing spondylitis	0.000109	0.00135	CcSEcCtD
Eletriptan—Myalgia—Dexamethasone—ankylosing spondylitis	0.000108	0.00133	CcSEcCtD
Eletriptan—Myalgia—Betamethasone—ankylosing spondylitis	0.000108	0.00133	CcSEcCtD
Eletriptan—Anxiety—Betamethasone—ankylosing spondylitis	0.000107	0.00133	CcSEcCtD
Eletriptan—Anxiety—Dexamethasone—ankylosing spondylitis	0.000107	0.00133	CcSEcCtD
Eletriptan—Discomfort—Betamethasone—ankylosing spondylitis	0.000106	0.00131	CcSEcCtD
Eletriptan—Discomfort—Dexamethasone—ankylosing spondylitis	0.000106	0.00131	CcSEcCtD
Eletriptan—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000106	0.00131	CcSEcCtD
Eletriptan—Pain—Prednisolone—ankylosing spondylitis	0.000106	0.00131	CcSEcCtD
Eletriptan—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000105	0.0013	CcSEcCtD
Eletriptan—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000104	0.00129	CcSEcCtD
Eletriptan—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000104	0.00128	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000104	0.00128	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000103	0.00128	CcSEcCtD
Eletriptan—Oedema—Betamethasone—ankylosing spondylitis	0.000103	0.00128	CcSEcCtD
Eletriptan—Oedema—Dexamethasone—ankylosing spondylitis	0.000103	0.00128	CcSEcCtD
Eletriptan—Insomnia—Triamcinolone—ankylosing spondylitis	0.000103	0.00127	CcSEcCtD
Eletriptan—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000103	0.00127	CcSEcCtD
Eletriptan—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000102	0.00126	CcSEcCtD
Eletriptan—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000102	0.00126	CcSEcCtD
Eletriptan—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000102	0.00126	CcSEcCtD
Eletriptan—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000102	0.00126	CcSEcCtD
Eletriptan—Visual impairment—Methotrexate—ankylosing spondylitis	0.000102	0.00126	CcSEcCtD
Eletriptan—Anaemia—Prednisone—ankylosing spondylitis	0.000102	0.00126	CcSEcCtD
Eletriptan—Shock—Betamethasone—ankylosing spondylitis	0.000101	0.00125	CcSEcCtD
Eletriptan—Shock—Dexamethasone—ankylosing spondylitis	0.000101	0.00125	CcSEcCtD
Eletriptan—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000101	0.00125	CcSEcCtD
Eletriptan—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000101	0.00125	CcSEcCtD
Eletriptan—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000101	0.00125	CcSEcCtD
Eletriptan—Agitation—Prednisone—ankylosing spondylitis	0.000101	0.00125	CcSEcCtD
Eletriptan—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000101	0.00124	CcSEcCtD
Eletriptan—Tachycardia—Betamethasone—ankylosing spondylitis	0.000101	0.00124	CcSEcCtD
Eletriptan—Angioedema—Prednisone—ankylosing spondylitis	0.000101	0.00124	CcSEcCtD
Eletriptan—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.0001	0.00124	CcSEcCtD
Eletriptan—Dyspepsia—Methylprednisolone—ankylosing spondylitis	9.98e-05	0.00123	CcSEcCtD
Eletriptan—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	9.97e-05	0.00123	CcSEcCtD
Eletriptan—Hyperhidrosis—Betamethasone—ankylosing spondylitis	9.97e-05	0.00123	CcSEcCtD
Eletriptan—Malaise—Prednisone—ankylosing spondylitis	9.92e-05	0.00123	CcSEcCtD
Eletriptan—Vertigo—Prednisone—ankylosing spondylitis	9.89e-05	0.00122	CcSEcCtD
Eletriptan—Syncope—Prednisone—ankylosing spondylitis	9.87e-05	0.00122	CcSEcCtD
Eletriptan—Tinnitus—Methotrexate—ankylosing spondylitis	9.85e-05	0.00122	CcSEcCtD
Eletriptan—Anorexia—Betamethasone—ankylosing spondylitis	9.83e-05	0.00122	CcSEcCtD
Eletriptan—Anorexia—Dexamethasone—ankylosing spondylitis	9.83e-05	0.00122	CcSEcCtD
Eletriptan—Urticaria—Prednisolone—ankylosing spondylitis	9.82e-05	0.00121	CcSEcCtD
Eletriptan—Fatigue—Triamcinolone—ankylosing spondylitis	9.8e-05	0.00121	CcSEcCtD
Eletriptan—Fatigue—Methylprednisolone—ankylosing spondylitis	9.78e-05	0.00121	CcSEcCtD
Eletriptan—Pain—Triamcinolone—ankylosing spondylitis	9.72e-05	0.0012	CcSEcCtD
Eletriptan—Loss of consciousness—Prednisone—ankylosing spondylitis	9.67e-05	0.0012	CcSEcCtD
Eletriptan—Hypotension—Betamethasone—ankylosing spondylitis	9.64e-05	0.00119	CcSEcCtD
Eletriptan—Hypotension—Dexamethasone—ankylosing spondylitis	9.64e-05	0.00119	CcSEcCtD
Eletriptan—Immune system disorder—Methotrexate—ankylosing spondylitis	9.54e-05	0.00118	CcSEcCtD
Eletriptan—Convulsion—Prednisone—ankylosing spondylitis	9.53e-05	0.00118	CcSEcCtD
Eletriptan—Hypertension—Prednisone—ankylosing spondylitis	9.5e-05	0.00117	CcSEcCtD
Eletriptan—Chills—Methotrexate—ankylosing spondylitis	9.48e-05	0.00117	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	9.4e-05	0.00116	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	9.4e-05	0.00116	CcSEcCtD
Eletriptan—Myalgia—Prednisone—ankylosing spondylitis	9.37e-05	0.00116	CcSEcCtD
Eletriptan—Arthralgia—Prednisone—ankylosing spondylitis	9.37e-05	0.00116	CcSEcCtD
Eletriptan—Feeling abnormal—Triamcinolone—ankylosing spondylitis	9.37e-05	0.00116	CcSEcCtD
Eletriptan—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	9.35e-05	0.00116	CcSEcCtD
Eletriptan—Anxiety—Prednisone—ankylosing spondylitis	9.34e-05	0.00115	CcSEcCtD
Eletriptan—Alopecia—Methotrexate—ankylosing spondylitis	9.34e-05	0.00115	CcSEcCtD
Eletriptan—Insomnia—Betamethasone—ankylosing spondylitis	9.33e-05	0.00115	CcSEcCtD
Eletriptan—Insomnia—Dexamethasone—ankylosing spondylitis	9.33e-05	0.00115	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	9.3e-05	0.00115	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	9.27e-05	0.00115	CcSEcCtD
Eletriptan—Paraesthesia—Dexamethasone—ankylosing spondylitis	9.26e-05	0.00114	CcSEcCtD
Eletriptan—Paraesthesia—Betamethasone—ankylosing spondylitis	9.26e-05	0.00114	CcSEcCtD
Eletriptan—Discomfort—Prednisone—ankylosing spondylitis	9.26e-05	0.00114	CcSEcCtD
Eletriptan—Hypersensitivity—Prednisolone—ankylosing spondylitis	9.11e-05	0.00113	CcSEcCtD
Eletriptan—Dyspepsia—Betamethasone—ankylosing spondylitis	9.08e-05	0.00112	CcSEcCtD
Eletriptan—Dyspepsia—Dexamethasone—ankylosing spondylitis	9.08e-05	0.00112	CcSEcCtD
Eletriptan—Urticaria—Triamcinolone—ankylosing spondylitis	9.03e-05	0.00112	CcSEcCtD
Eletriptan—Urticaria—Methylprednisolone—ankylosing spondylitis	9.01e-05	0.00111	CcSEcCtD
Eletriptan—Dysgeusia—Methotrexate—ankylosing spondylitis	9.01e-05	0.00111	CcSEcCtD
Eletriptan—Body temperature increased—Triamcinolone—ankylosing spondylitis	8.99e-05	0.00111	CcSEcCtD
Eletriptan—Oedema—Prednisone—ankylosing spondylitis	8.98e-05	0.00111	CcSEcCtD
Eletriptan—Abdominal pain—Methylprednisolone—ankylosing spondylitis	8.97e-05	0.00111	CcSEcCtD
Eletriptan—Decreased appetite—Betamethasone—ankylosing spondylitis	8.97e-05	0.00111	CcSEcCtD
Eletriptan—Decreased appetite—Dexamethasone—ankylosing spondylitis	8.97e-05	0.00111	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	8.9e-05	0.0011	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	8.9e-05	0.0011	CcSEcCtD
Eletriptan—Back pain—Methotrexate—ankylosing spondylitis	8.9e-05	0.0011	CcSEcCtD
Eletriptan—Fatigue—Betamethasone—ankylosing spondylitis	8.89e-05	0.0011	CcSEcCtD
Eletriptan—Fatigue—Dexamethasone—ankylosing spondylitis	8.89e-05	0.0011	CcSEcCtD
Eletriptan—Shock—Prednisone—ankylosing spondylitis	8.84e-05	0.00109	CcSEcCtD
Eletriptan—Pain—Betamethasone—ankylosing spondylitis	8.82e-05	0.00109	CcSEcCtD
Eletriptan—Pain—Dexamethasone—ankylosing spondylitis	8.82e-05	0.00109	CcSEcCtD
Eletriptan—Nervous system disorder—Prednisone—ankylosing spondylitis	8.81e-05	0.00109	CcSEcCtD
Eletriptan—Tachycardia—Prednisone—ankylosing spondylitis	8.77e-05	0.00108	CcSEcCtD
Eletriptan—Skin disorder—Prednisone—ankylosing spondylitis	8.72e-05	0.00108	CcSEcCtD
Eletriptan—Hyperhidrosis—Prednisone—ankylosing spondylitis	8.68e-05	0.00107	CcSEcCtD
Eletriptan—Anorexia—Prednisone—ankylosing spondylitis	8.56e-05	0.00106	CcSEcCtD
Eletriptan—Ill-defined disorder—Methotrexate—ankylosing spondylitis	8.53e-05	0.00105	CcSEcCtD
Eletriptan—Anaemia—Methotrexate—ankylosing spondylitis	8.5e-05	0.00105	CcSEcCtD
Eletriptan—Feeling abnormal—Betamethasone—ankylosing spondylitis	8.5e-05	0.00105	CcSEcCtD
Eletriptan—Feeling abnormal—Dexamethasone—ankylosing spondylitis	8.5e-05	0.00105	CcSEcCtD
Eletriptan—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	8.43e-05	0.00104	CcSEcCtD
Eletriptan—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	8.43e-05	0.00104	CcSEcCtD
Eletriptan—Hypersensitivity—Triamcinolone—ankylosing spondylitis	8.37e-05	0.00104	CcSEcCtD
Eletriptan—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	8.36e-05	0.00103	CcSEcCtD
Eletriptan—Malaise—Methotrexate—ankylosing spondylitis	8.29e-05	0.00103	CcSEcCtD
Eletriptan—Vertigo—Methotrexate—ankylosing spondylitis	8.26e-05	0.00102	CcSEcCtD
Eletriptan—Leukopenia—Methotrexate—ankylosing spondylitis	8.23e-05	0.00102	CcSEcCtD
Eletriptan—Urticaria—Betamethasone—ankylosing spondylitis	8.19e-05	0.00101	CcSEcCtD
Eletriptan—Urticaria—Dexamethasone—ankylosing spondylitis	8.19e-05	0.00101	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	8.18e-05	0.00101	CcSEcCtD
Eletriptan—Dizziness—Prednisolone—ankylosing spondylitis	8.17e-05	0.00101	CcSEcCtD
Eletriptan—Asthenia—Triamcinolone—ankylosing spondylitis	8.15e-05	0.00101	CcSEcCtD
Eletriptan—Body temperature increased—Dexamethasone—ankylosing spondylitis	8.15e-05	0.00101	CcSEcCtD
Eletriptan—Body temperature increased—Betamethasone—ankylosing spondylitis	8.15e-05	0.00101	CcSEcCtD
Eletriptan—Abdominal pain—Betamethasone—ankylosing spondylitis	8.15e-05	0.00101	CcSEcCtD
Eletriptan—Abdominal pain—Dexamethasone—ankylosing spondylitis	8.15e-05	0.00101	CcSEcCtD
Eletriptan—Asthenia—Methylprednisolone—ankylosing spondylitis	8.14e-05	0.00101	CcSEcCtD
Eletriptan—Insomnia—Prednisone—ankylosing spondylitis	8.12e-05	0.001	CcSEcCtD
Eletriptan—Paraesthesia—Prednisone—ankylosing spondylitis	8.06e-05	0.000997	CcSEcCtD
Eletriptan—Pruritus—Triamcinolone—ankylosing spondylitis	8.04e-05	0.000994	CcSEcCtD
Eletriptan—Cough—Methotrexate—ankylosing spondylitis	8.03e-05	0.000992	CcSEcCtD
Eletriptan—Pruritus—Methylprednisolone—ankylosing spondylitis	8.02e-05	0.000992	CcSEcCtD
Eletriptan—Convulsion—Methotrexate—ankylosing spondylitis	7.97e-05	0.000985	CcSEcCtD
Eletriptan—Dyspepsia—Prednisone—ankylosing spondylitis	7.91e-05	0.000977	CcSEcCtD
Eletriptan—Arthralgia—Methotrexate—ankylosing spondylitis	7.83e-05	0.000968	CcSEcCtD
Eletriptan—Myalgia—Methotrexate—ankylosing spondylitis	7.83e-05	0.000968	CcSEcCtD
Eletriptan—Decreased appetite—Prednisone—ankylosing spondylitis	7.81e-05	0.000965	CcSEcCtD
Eletriptan—Rash—Prednisolone—ankylosing spondylitis	7.79e-05	0.000963	CcSEcCtD
Eletriptan—Dermatitis—Prednisolone—ankylosing spondylitis	7.79e-05	0.000963	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	7.78e-05	0.000961	CcSEcCtD
Eletriptan—Diarrhoea—Methylprednisolone—ankylosing spondylitis	7.76e-05	0.000959	CcSEcCtD
Eletriptan—Fatigue—Prednisone—ankylosing spondylitis	7.74e-05	0.000957	CcSEcCtD
Eletriptan—Headache—Prednisolone—ankylosing spondylitis	7.74e-05	0.000957	CcSEcCtD
Eletriptan—Discomfort—Methotrexate—ankylosing spondylitis	7.74e-05	0.000956	CcSEcCtD
Eletriptan—Constipation—Prednisone—ankylosing spondylitis	7.68e-05	0.00095	CcSEcCtD
Eletriptan—Confusional state—Methotrexate—ankylosing spondylitis	7.57e-05	0.000936	CcSEcCtD
Eletriptan—Dizziness—Triamcinolone—ankylosing spondylitis	7.52e-05	0.000929	CcSEcCtD
Eletriptan—Dizziness—Methylprednisolone—ankylosing spondylitis	7.5e-05	0.000927	CcSEcCtD
Eletriptan—Feeling abnormal—Prednisone—ankylosing spondylitis	7.4e-05	0.000915	CcSEcCtD
Eletriptan—Asthenia—Dexamethasone—ankylosing spondylitis	7.4e-05	0.000915	CcSEcCtD
Eletriptan—Asthenia—Betamethasone—ankylosing spondylitis	7.4e-05	0.000915	CcSEcCtD
Eletriptan—Nervous system disorder—Methotrexate—ankylosing spondylitis	7.36e-05	0.00091	CcSEcCtD
Eletriptan—Gastrointestinal pain—Prednisone—ankylosing spondylitis	7.34e-05	0.000908	CcSEcCtD
Eletriptan—Nausea—Prednisolone—ankylosing spondylitis	7.34e-05	0.000908	CcSEcCtD
Eletriptan—Pruritus—Betamethasone—ankylosing spondylitis	7.3e-05	0.000902	CcSEcCtD
Eletriptan—Pruritus—Dexamethasone—ankylosing spondylitis	7.3e-05	0.000902	CcSEcCtD
Eletriptan—Skin disorder—Methotrexate—ankylosing spondylitis	7.29e-05	0.000901	CcSEcCtD
Eletriptan—Hyperhidrosis—Methotrexate—ankylosing spondylitis	7.26e-05	0.000897	CcSEcCtD
Eletriptan—Vomiting—Triamcinolone—ankylosing spondylitis	7.23e-05	0.000893	CcSEcCtD
Eletriptan—Vomiting—Methylprednisolone—ankylosing spondylitis	7.21e-05	0.000891	CcSEcCtD
Eletriptan—Rash—Triamcinolone—ankylosing spondylitis	7.17e-05	0.000886	CcSEcCtD
Eletriptan—Dermatitis—Triamcinolone—ankylosing spondylitis	7.16e-05	0.000885	CcSEcCtD
Eletriptan—Anorexia—Methotrexate—ankylosing spondylitis	7.15e-05	0.000885	CcSEcCtD
Eletriptan—Rash—Methylprednisolone—ankylosing spondylitis	7.15e-05	0.000884	CcSEcCtD
Eletriptan—Dermatitis—Methylprednisolone—ankylosing spondylitis	7.14e-05	0.000883	CcSEcCtD
Eletriptan—Urticaria—Prednisone—ankylosing spondylitis	7.13e-05	0.000882	CcSEcCtD
Eletriptan—Headache—Triamcinolone—ankylosing spondylitis	7.12e-05	0.00088	CcSEcCtD
Eletriptan—Headache—Methylprednisolone—ankylosing spondylitis	7.1e-05	0.000878	CcSEcCtD
Eletriptan—Abdominal pain—Prednisone—ankylosing spondylitis	7.1e-05	0.000878	CcSEcCtD
Eletriptan—Body temperature increased—Prednisone—ankylosing spondylitis	7.1e-05	0.000878	CcSEcCtD
Eletriptan—Diarrhoea—Betamethasone—ankylosing spondylitis	7.06e-05	0.000872	CcSEcCtD
Eletriptan—Diarrhoea—Dexamethasone—ankylosing spondylitis	7.06e-05	0.000872	CcSEcCtD
Eletriptan—Hypotension—Methotrexate—ankylosing spondylitis	7.01e-05	0.000867	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	6.84e-05	0.000845	CcSEcCtD
Eletriptan—Dizziness—Betamethasone—ankylosing spondylitis	6.82e-05	0.000843	CcSEcCtD
Eletriptan—Dizziness—Dexamethasone—ankylosing spondylitis	6.82e-05	0.000843	CcSEcCtD
Eletriptan—Insomnia—Methotrexate—ankylosing spondylitis	6.79e-05	0.000839	CcSEcCtD
Eletriptan—Nausea—Triamcinolone—ankylosing spondylitis	6.75e-05	0.000835	CcSEcCtD
Eletriptan—Paraesthesia—Methotrexate—ankylosing spondylitis	6.74e-05	0.000833	CcSEcCtD
Eletriptan—Nausea—Methylprednisolone—ankylosing spondylitis	6.74e-05	0.000833	CcSEcCtD
Eletriptan—Dyspnoea—Methotrexate—ankylosing spondylitis	6.69e-05	0.000827	CcSEcCtD
Eletriptan—Somnolence—Methotrexate—ankylosing spondylitis	6.67e-05	0.000825	CcSEcCtD
Eletriptan—Hypersensitivity—Prednisone—ankylosing spondylitis	6.62e-05	0.000818	CcSEcCtD
Eletriptan—Dyspepsia—Methotrexate—ankylosing spondylitis	6.61e-05	0.000817	CcSEcCtD
Eletriptan—Vomiting—Betamethasone—ankylosing spondylitis	6.56e-05	0.000811	CcSEcCtD
Eletriptan—Vomiting—Dexamethasone—ankylosing spondylitis	6.56e-05	0.000811	CcSEcCtD
Eletriptan—Decreased appetite—Methotrexate—ankylosing spondylitis	6.52e-05	0.000807	CcSEcCtD
Eletriptan—Rash—Betamethasone—ankylosing spondylitis	6.5e-05	0.000804	CcSEcCtD
Eletriptan—Rash—Dexamethasone—ankylosing spondylitis	6.5e-05	0.000804	CcSEcCtD
Eletriptan—Dermatitis—Dexamethasone—ankylosing spondylitis	6.5e-05	0.000803	CcSEcCtD
Eletriptan—Dermatitis—Betamethasone—ankylosing spondylitis	6.5e-05	0.000803	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	6.48e-05	0.000801	CcSEcCtD
Eletriptan—Fatigue—Methotrexate—ankylosing spondylitis	6.47e-05	0.0008	CcSEcCtD
Eletriptan—Headache—Dexamethasone—ankylosing spondylitis	6.46e-05	0.000799	CcSEcCtD
Eletriptan—Headache—Betamethasone—ankylosing spondylitis	6.46e-05	0.000799	CcSEcCtD
Eletriptan—Asthenia—Prednisone—ankylosing spondylitis	6.44e-05	0.000797	CcSEcCtD
Eletriptan—Pain—Methotrexate—ankylosing spondylitis	6.42e-05	0.000794	CcSEcCtD
Eletriptan—Pruritus—Prednisone—ankylosing spondylitis	6.35e-05	0.000786	CcSEcCtD
Eletriptan—Feeling abnormal—Methotrexate—ankylosing spondylitis	6.19e-05	0.000765	CcSEcCtD
Eletriptan—Diarrhoea—Prednisone—ankylosing spondylitis	6.15e-05	0.00076	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	6.14e-05	0.000759	CcSEcCtD
Eletriptan—Nausea—Dexamethasone—ankylosing spondylitis	6.13e-05	0.000757	CcSEcCtD
Eletriptan—Nausea—Betamethasone—ankylosing spondylitis	6.13e-05	0.000757	CcSEcCtD
Eletriptan—Urticaria—Methotrexate—ankylosing spondylitis	5.96e-05	0.000737	CcSEcCtD
Eletriptan—Dizziness—Prednisone—ankylosing spondylitis	5.94e-05	0.000734	CcSEcCtD
Eletriptan—Abdominal pain—Methotrexate—ankylosing spondylitis	5.93e-05	0.000734	CcSEcCtD
Eletriptan—Body temperature increased—Methotrexate—ankylosing spondylitis	5.93e-05	0.000734	CcSEcCtD
Eletriptan—Vomiting—Prednisone—ankylosing spondylitis	5.71e-05	0.000706	CcSEcCtD
Eletriptan—Rash—Prednisone—ankylosing spondylitis	5.66e-05	0.0007	CcSEcCtD
Eletriptan—Dermatitis—Prednisone—ankylosing spondylitis	5.66e-05	0.000699	CcSEcCtD
Eletriptan—Headache—Prednisone—ankylosing spondylitis	5.63e-05	0.000696	CcSEcCtD
Eletriptan—Hypersensitivity—Methotrexate—ankylosing spondylitis	5.53e-05	0.000684	CcSEcCtD
Eletriptan—Asthenia—Methotrexate—ankylosing spondylitis	5.39e-05	0.000666	CcSEcCtD
Eletriptan—Nausea—Prednisone—ankylosing spondylitis	5.33e-05	0.00066	CcSEcCtD
Eletriptan—Pruritus—Methotrexate—ankylosing spondylitis	5.31e-05	0.000657	CcSEcCtD
Eletriptan—Diarrhoea—Methotrexate—ankylosing spondylitis	5.14e-05	0.000635	CcSEcCtD
Eletriptan—Dizziness—Methotrexate—ankylosing spondylitis	4.96e-05	0.000614	CcSEcCtD
Eletriptan—Vomiting—Methotrexate—ankylosing spondylitis	4.77e-05	0.00059	CcSEcCtD
Eletriptan—Rash—Methotrexate—ankylosing spondylitis	4.73e-05	0.000585	CcSEcCtD
Eletriptan—Dermatitis—Methotrexate—ankylosing spondylitis	4.73e-05	0.000585	CcSEcCtD
Eletriptan—Headache—Methotrexate—ankylosing spondylitis	4.7e-05	0.000581	CcSEcCtD
Eletriptan—Nausea—Methotrexate—ankylosing spondylitis	4.46e-05	0.000551	CcSEcCtD
